JUPW News and Press, Jupiter Wellness Inc. From 02/02/22

Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness , Inc. (NASDAQ:JUPW ) today announced that its CEO Brian John and Next Frontier Pharmaceutica...

Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution Next Frontier Pharmaceuticals has completed a pre-IND meeting with the FDA, and intends to commence Phase II Clinical Trials in the 2H 2022; indus...

Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness , Inc. (NASDAQ:JUPW) today announced it its board of directors approved a $5.0 million share buyback program which expires on J...

SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceuticals JUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness , Inc. (NAS...

Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics Benuvia has begun focusing on Psilocybin, DMT, and MDMA. Benuvia's 83,000 square foot synthetic compound manufacturing facility is permitted by the U.S. DEA for Schedule I to I...

JUPITER, FL / ACCESSWIRE / January 10, 2022 / Jupiter Wellness Issues Letter to Stockholders: Dear Fellow Stockholders, Jupiter Wellness, Inc. ("Jupiter", or the "Company"), has, we believe, accomplished big things since it became publicly traded on November 1, 2020. Our definitive agreeme...

NEW YORK, NY / ACCESSWIRE / December 31, 2021 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Jupiter Wellness, Inc. (NASDAQ:JUPW) and Next Frontier Pharmaceuticals, Inc. is fair to Jupiter shareholders. Under the terms of the transaction, Next...

Gainers: Zhangmen Education (NYSE:ZME) +474%. 22nd Century Group (NASDAQ:XXII) +49%. Pasithea Therapeutics (NASDAQ:KTTA) +36%. Theseus Pharmaceuticals (NASDAQ:THRX) +32%. Qualigen Therapeutics (NASDAQ:QLGN) +32%. Allakos (NASDAQ:ALLK) +27%. REE Automotive (NASDAQ:REE) +26%. View (NASDAQ:VIEW)...

NEW YORK, NY / ACCESSWIRE / December 23, 2021 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Jupiter Wellness, Inc. (NASDAQ:JUPW) and Next Frontier Pharmaceuticals, Inc. is fair to Jupiter shareholders. Under the terms of the transaction, Next F...

Jupiter Wellness (NASDAQ:JUPW) has signed an agreement to acquire Next Frontier Pharmaceuticals, through a merger with a subsidiary of Jupiter Wellness. JUPW shares down 8.9% premarket at $1.23. Under the terms of the transaction, Next Frontier Pharma's stockholders will receive sha...